Partial Prostate Salvage High Dose Rate Brachytherapy
Recruiting
N/A
Interventional Study
Recurrent Prostate Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 45 and older
- Sex
- Male
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- British Columbia Cancer Agency · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A dose-response relationship for radiation in the management of prostate cancer is well established. Local recurrence of prostate cancer after external beam radiotherapy occurs in at least 40% of patients treated because of inability to deliver sufficient dose through external beam techniques. These patients respond well to re-irradiation using brachytherapy with about 50% of selected patients rem…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age \>45 and Life expectancy \>10 years
* Previous External Beam Radiotherapy (EBRT) or LDR brachytherapy w
* \> 3 year interval since EBRT or LDR Brachytherapy
* No late toxicity from prior EBRT ≥ grade 2
* PSA \> nadir + 2 ng/ml and \< 10 ng/ml
* PSA Doubling time \> 6 month…
Contacts